Literature DB >> 9878866

The relationship between ocular melatonin and dopamine rhythms in the pigeon: effects of melatonin inhibition on dopamine release.

A Adachi1, Y Suzuki, T Nogi, S Ebihara.   

Abstract

Our previous study has shown that the phases of circadian rhythms of ocular melatonin and dopamine are always opposite and intraocular melatonin injection suppresses dopamine release. Therefore, it is possible that dopamine rhythms result from inhibitory action of melatonin. We have examined this possibility in the following experiments. In the first experiment effects of continuous light on melatonin and dopamine release were examined. The data indicated that continuous light exposure resulted in loss of circadian rhythmicity of melatonin and dopamine by suppressing melatonin and enhancing dopamine levels throughout the day. To further examine the effects of light in the second experiment, 2 h light pulse was applied during the night, then temporal changes of melatonin and dopamine release were studied. The light pulse rapidly suppressed melatonin release, whereas it rapidly increased dopamine release. These changes occurred within 30 min in both melatonin and dopamine. However, the recovery after the cessation of the light stimulus was slower in melatonin than dopamine. In the third experiment it was tested if dopamine release was increased by lowering melatonin release with an intraocular injection of the D2 agonist, quinpirol. Although quinpirol strongly inhibited melatonin release independently of the time of injection, dopamine did not always increase by the inhibition of melatonin. These results indicate that ocular dopamine rhythms are not simply produced by melatonin inhibitory action. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9878866     DOI: 10.1016/s0006-8993(98)01077-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Dopamine in the Turkey retina-an impact of environmental light, circadian clock, and melatonin.

Authors:  Anna Lorenc-Duda; Małgorzata Berezińska; Anna Urbańska; Krystyna Gołembiowska; Jolanta B Zawilska
Journal:  J Mol Neurosci       Date:  2008-10-25       Impact factor: 3.444

2.  Somatostatin peptides produce multiple effects on gating properties of native cone photoreceptor cGMP-gated channels that depend on circadian phase and previous illumination.

Authors:  Shih-Kuo Chen; Gladys Y-P Ko; Stuart E Dryer
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

3.  Ontogeny of central melatonin receptors in tadpoles of the anuran Rana perezi: modulation of dopamine release.

Authors:  Esther Isorna; Ana Isabel Guijarro; María Jesús Delgado; Marcos A López-Patiño; Nuria de Pedro; Angel Luis Alonso-Gómez
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2005-08-02       Impact factor: 1.836

4.  A circadian clock in the fish retina regulates dopamine release via activation of melatonin receptors.

Authors:  Christophe Ribelayga; Yu Wang; Stuart C Mangel
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

Review 5.  The circadian clock system in the mammalian retina.

Authors:  Gianluca Tosini; Nikita Pozdeyev; Katsuhiko Sakamoto; P Michael Iuvone
Journal:  Bioessays       Date:  2008-07       Impact factor: 4.345

6.  Melatonin blocks inhibitory effects of prolactin on photoperiodic induction of gain in body mass, testicular growth and feather regeneration in the migratory male redheaded bunting (Emberiza bruniceps).

Authors:  Amit K Trivedi; Sangeeta Rani; Vinod Kumar
Journal:  Reprod Biol Endocrinol       Date:  2004-11-26       Impact factor: 5.211

7.  Expression of Melatonin and Dopamine D3 Receptor Heteromers in Eye Ciliary Body Epithelial Cells and Negative Correlation with Ocular Hypertension.

Authors:  Irene Reyes-Resina; Hanan Awad Alkozi; Anna Del Ser-Badia; Juan Sánchez-Naves; Jaume Lillo; Jasmina Jiménez; Jesús Pintor; Gemma Navarro; Rafael Franco
Journal:  Cells       Date:  2020-01-08       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.